Big Pharma isn't the only sector of the life sciences market seeing action. Little Pharma has seen its own flurry of acquisitions lately. What's driving the market? Many factors are at play [...]
The innovative technology market is flush with M&A activity. This action will continue to accelerate as 2015 progresses with corporate buyers making strategic acquisitions to [...]
Retailers rounded out 2014 with strong sales performance and the longest holiday shopping season on record, leaving chief financial officers (CFOs) feeling sunny and optimistic [...]
On January 1, 2011 about 8,000 Baby Boomers (people born between 1946 – 1964) turned 65 years of age. Every day for the next 18 years, others will turn 65 at the [...]
“Do I really understand the purpose of an M&A advisor?” This is a question thousands of business owners ask themselves every year when they embark on the [...]
Lacking full comprehension of the implications behind assumptions applied in reserves valuations can result in sub-optimal decision-making for lenders and [...]
Although many industry experts are still reluctant to call the ongoing resurgence in U.S. manufacturing a widespread phenomenon, several trends lend support to the [...]
We recently observed a compelling discussion of the key trends driving evolution and increased activity in middle market deal making. Alongside these [...]
Cash and credit are readily available to support M&A in the United States and corporate America indicates an uptick in desire for dealmaking according to ninth [...]